Changes in serum tryptophan catabolism as an indicator of disease activity in adult T-cell leukemia/lymphoma

Leukemia and Lymphoma

Volumn 50, Issue 8, 2009, Pages 1372-1374

  Hoshi, Masato ^a   Ito, Hiroyasu ^a   Fujigaki, Hidetsugu ^a   Takemura, Masao ^a   Takahashi, Takeshi ^b   Tomita, Eiichi ^b   Ohyama, Masami ^c   Tanaka, Ryo ^a   Ohtaki, Hirofumi ^a   Saito, Kuniaki ^a,d   Seishima, Mitsuru ^a  

^a GIFU UNIVERSITY   (Japan)

^b Gifu Municipal Hospital   (Japan)

^c Kisogawa Municipal Hospital   (Japan)

^d KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; KYNURENINE; PREDNISONE; RANIMUSTINE; SOLUBLE INTERLEUKIN 2 RECEPTOR; TRYPTOPHAN; VINCRISTINE; VINDESINE; ANTINEOPLASTIC AGENT; CHOP PROTOCOL; GRANULOCYTE COLONY STIMULATING FACTOR; INDOLEAMINE 2,3 DIOXYGENASE; INTERLEUKIN 2 RECEPTOR; NITROSOUREA DERIVATIVE; TRYPTOPHAN 2,3 DIOXYGENASE; TUMOR PROTEIN;

ACUTE DISEASE; AGED; CANCER CHEMOTHERAPY; CANCER PATIENT; CASE REPORT; DISEASE ACTIVITY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LETTER; PRIORITY JOURNAL; SPECTROFLUOROMETRY; T CELL LEUKEMIA; TRYPTOPHAN METABOLISM; BLOOD; CHEMICALLY INDUCED DISORDER; DRUG MONITORING; ENZYMOLOGY; METABOLISM; NEUTROPENIA; TUMOR EMBOLISM;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; DRUG MONITORING; ETOPOSIDE; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; KYNURENINE; LEUKEMIA-LYMPHOMA, ADULT T-CELL; METABOLIC NETWORKS AND PATHWAYS; NEOPLASM PROTEINS; NEOPLASTIC CELLS, CIRCULATING; NEUTROPENIA; NITROSOUREA COMPOUNDS; PREDNISONE; RECEPTORS, INTERLEUKIN-2; TRYPTOPHAN; TRYPTOPHAN OXYGENASE; VINCRISTINE; VINDESINE;

EID: 77649317717     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190903045393     Document Type: Letter

References (15)

1. Poiesz BJ, Ruscetti FW, Mier JW, et al. T-cell lines established from human T-lymphocytic neoplasias by direct response to T-cell growth factor. Proc Natl Acad Sci USA 1980;77:6815-6819. (Pubitemid 11163491)
2. Uchiyama T. Human T cell leukemia virus type I (HTLV-I) and human diseases. Annu Rev Immunol 1997;15:15-37. (Pubitemid 27169273)
3. Uchiyama T, Yodoi J, Sagawa K, et al. Adult T-cell leukemia: clinical and hematologic features of 16 cases. Blood 1977;50:481-492. (Pubitemid 8180432)
4. Hinuma Y, Nagata K, Hanaoka M, et al. Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera. Proc Natl Acad Sci USA 1981;78:6476-6480. (Pubitemid 12179735)
5. Taylor MW, Feng GS. Relationship between interferongamma, indoleamine 2, 3-dioxygenase, and tryptophan catabolism. FASEB J 1991;5:2516-2522. (Pubitemid 21905800)
6. Frumento G, Rotondo R, Tonetti M, et al. Tryptophanderived catabolites are responsible for inhibition of T and natural killer cell proliferation induced by indoleamine 2, 3-dioxygenase. J Exp Med 2002;196:459-468.
7. Huang A, Fuchs D, Widner B, et al. Serum tryptophan decrease correlates with immune activation and impaired quality of life in colorectal cancer. Br J Cancer 2002;86:1691-1696. (Pubitemid 34712909)
8. Hoshi M, Ito H, Fujigaki H, et al. Indoleamine 2, 3-dioxygenase is highly expressed in human adult T-cell leukemia/lymphoma and chemotherapy changes tryptophan catabolism in serum and reduced activity. Leuk Res 2009;33:39-45.
9. Giusti RM, Maloney EM, Hanchard B, et al. Differential patterns of serum biomarkers of immune activation in human T-cell lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis, and adult T-cell leukemia/lymphoma. Cancer Epidemiol Biomarkers Prev 1996;5:699-704.
10. Popov A, Schultze JL. IDO-expressing regulatory dendritic cells in cancer and chronic infection. J Mol Med 2008;86:145-160. (Pubitemid 351172124)
11. Lee GK, Park HJ, Macleod M, et al. Tryptophan deprivation sensitizes activated T cells to apoptosis prior to cell division. Immunology 2002;107:452-460. (Pubitemid 36693650)
12. Platten M, Ho PP, Youssef S, et al. Treatment of autoimmune neuroinflammation with a synthetic tryptophan metabolite. Science 2005;310:850-855. (Pubitemid 41567343)
13. Terness P, Bauer TM, Rose L, et al. Inhibition of allogeneic T cell proliferation by indoleamine 2, 3-dioxygenase-expressing dendritic cells: mediation of suppression by tryptophan metabolites. J Exp Med 2002;196:447-457.
14. Astigiano S, Morandi B, Costa R, et al. Eosinophil granulocytes account for indoleamine 2, 3-dioxygenase-mediated immune escape in human non-small cell lung cancer. Neoplasia 2005;7:390-396. (Pubitemid 40664228)
15. Hou DY, Muller AJ, Sharma MD, et al. Inhibition of indoleamine 2, 3-dioxygenase in dendritic cells by stereoisomers of 1-methyl-tryptophan correlates with antitumor responses. Cancer Res 2007;67:792-801. (Pubitemid 46192220)